This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Riley, M. S. Articles by Wasserman, K. Search for Related Content PubMed PubMed Citation Articles by Riley, M. S. Articles by Wasserman, K.

CLINICAL STUDIES

Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide

^a Division of Respiratory and Critical Care Physiology and Medicine, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, Torrance, California, USA
^b Division of Cardiology, St. John’s Cardiovascular Research Center, Harbor-UCLA Medical Center, Torrance, California, USA

Manuscript received May 17, 1999; revised manuscript received February 1, 2000, accepted March 30, 2000.

Reprint requests and correspondence: Dr. Marshall S. Riley, Belfast City Hospital, 93 Lisburn Road, Belfast, BT9 7AB, Northern Ireland
mriley{at}compuserve.com

OBJECTIVES

The purpose of this study was to investigate the responses of patients with primary pulmonary hypertension (PPH) to constant work rate exercise and to examine the effect of nitric oxide (NO) inhalation.

BACKGROUND

Maximal exercise tolerance is reduced in PPH, but gas exchange responses to constant work rate exercise have not been defined. We hypothesized that increased pulmonary vascular resistance in PPH would reduce the rate of rise of minute oxygen consumption in response to a given work rate. Because NO may lower pulmonary vascular pressures in PPH, we also postulated that inhaled NO might ameliorate gas exchange abnormalities.

METHODS

Nine PPH patients and nine matched normal subjects performed 6-min duration constant work rate cycle ergometry exercise (33.9 ± 13.4 W). Patients performed two experiments: breathing air and breathing air with NO (20 ppm). Preexercise right ventricular systolic pressure was assessed by Doppler echocardiography. Normal subjects performed the air experiment only. Gas exchange and heart rate responses were characterized by fitting monoexponential curves.

RESULTS

In PPH patients, resting right ventricular systolic pressure fell after NO inhalation (from 83.8 ± 16.9 to 73.9 ± 21.6 mm Hg, p < 0.01, analysis of variance with Tukey correction), but not after breathing air alone (from 88.0 ± 20.8 to 86.7 ± 20.6 mm Hg, p = NS). Nitric oxide did not affect any of the gas exchange responses. Minute oxygen consumption was similar by the end of exercise in patients and normals, but increased more slowly in patients (mean response time [MRT]: air, 63.17 ± 14.99 s; NO, 61.60 ± 15.45 s) than normals (MRT, 32.73 ± 14.79, p < 0.01, analysis of variance, Tukey test). Minute oxygen consumption kinetics during recovery were slower in patients (MRT air: 82.50 ± 29.94 s; NO, 73.36 ± 15.87 s) than in normals (MRT, 34.59 ± 7.11 s, p < 0.01). Heart rate kinetics during exercise and recovery were significantly slower in patients than in normals.

CONCLUSIONS

The cardiac output response is impaired in PPH. Nitric oxide lowered pulmonary artery pressure at rest, but failed to improve exercise gas exchange responses.

Abbreviations and Acronyms   EPOC = excess postexercise oxygen consumption   LAT = lactic acidosis threshold   MRT = mean response time   NO = nitric oxide   PCr = phosphocreatine   PPH = primary pulmonary hypertension   RVSP = right ventricular systolic pressure   SpO2 = hemoglobin saturation measured by pulse oximetry   CO2 = minute carbon dioxide production   E = minute ventilation   O2 = minute oxygen consumption

This article has been cited by other articles:

				M. Fischler, M. Maggiorini, L. Dorschner, J. Debrunner, A. Bernheim, S. Kiencke, H. Mairbaurl, K. E. Bloch, R. Naeije, and H. P. B.-L. Rocca Dexamethasone But Not Tadalafil Improves Exercise Capacity in Adults Prone to High-Altitude Pulmonary Edema Am. J. Respir. Crit. Care Med., August 15, 2009; 180(4): 346 - 352. [Abstract] [Full Text] [PDF]

				M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 14S - 34S. [Abstract] [Full Text] [PDF]

				H.-Y. Ong, C. S. O'Dochartaigh, S. Lovell, V. H. Patterson, K. Wasserman, D. P. Nicholls, and M. S. Riley Gas Exchange Responses to Constant Work-Rate Exercise in Patients with Glycogenosis Type V and VII Am. J. Respir. Crit. Care Med., June 1, 2004; 169(11): 1238 - 1244. [Abstract] [Full Text] [PDF]

				H. H. Leuchte, M. Holzapfel, R. A. Baumgartner, I. Ding, C. Neurohr, M. Vogeser, T. Kolbe, M. Schwaiblmair, and J. Behr Clinical significance of brain natriuretic peptide in primary pulmonary hypertension J. Am. Coll. Cardiol., March 3, 2004; 43(5): 764 - 770. [Abstract] [Full Text] [PDF]

				B. G. Krohn The enigma of primary pulmonary hypertension J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1476 - 1477. [Full Text] [PDF]